Article Page

Abstract

A process model of quantum mechanics utilizes a combinatorial game to generate a discrete and finite causal space, which can be defined as a self-consistent quantum mechanics. An emergent space-time and continuous wave function arise through a non-uniform interpolation process. Standard non-relativistic quantum mechanics emerges under the limit of infinite information (the causal space grows to infinity) and infinitesimal scale (the separation between points goes to zero). This model has the potential to address a computational target fishing mining machinery Process Model of Quantum Mechanics Circular Scale of Time and Energy of a Quantum State Calculated from the Schrödinger Perturbation Theory as an Identification tool for predicting therapeutic potential of GLP-1, INGAP-P/IGLHDPSHGTLPNGS peptide mimetic insulinotropic of high-potency compounds.

Keywords

Process Theory; Quantum Foundations; Discrete Models; Emergent Models; Process Model; Quantum Mechanics; Circular Scale; Time and Energy; Quantum State Calculated; Schrödinger Perturbation Theory; computational target fishing; mining machinery; Identification tool; predicting therapeutic potential; GLP-1, INGAP-P; IGLHDPSHGTLPNGS peptide mimetic; insulinotropic; high-potency; compounds; chemogenomic databases;

Article Type

Research Article – Abstract

Publication history

Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017

Citation

Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) A computational target fishing mining machinery Process Model of Quantum Mechanics Circular Scale of Time and Energy of a Quantum State Calculated from the Schrödinger Perturbation Theory as an Identification tool for predicting therapeutic potential of GLP-1, INGAP-P/IGLHDPSHGTLPNGS peptide mimetic insulinotropic of high-potency compounds.

Authors Info

Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;

George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;

E-mail: biogeneadrug@gmail.com

File not available